Kazia Therapeutics (KZIA)

• Market cap: $12.9M
• 1 day: -0.77%
• 5 days: 8.39%
• 1 month: 18.14%
• 3 months: -7.07%
• 6 months: 117.7%
• Year to date: -11.43%
• 1 year: -76.44%
• 5 years: -97.27%
• 10 years: -98.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Employees: 7